163.61
Align Technology Inc stock is traded at $163.61, with a volume of 844.54K.
It is up +0.35% in the last 24 hours and down -16.55% over the past month.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
See More
Previous Close:
$163.04
Open:
$162.9
24h Volume:
844.54K
Relative Volume:
0.74
Market Cap:
$11.72B
Revenue:
$4.10B
Net Income/Loss:
$429.89M
P/E Ratio:
27.44
EPS:
5.9621
Net Cash Flow:
$691.59M
1W Performance:
+4.04%
1M Performance:
-16.55%
6M Performance:
+14.77%
1Y Performance:
-5.21%
Align Technology Inc Stock (ALGN) Company Profile
Name
Align Technology Inc
Sector
Industry
Phone
408-470-1000
Address
410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE, CA
Compare ALGN vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ALGN
Align Technology Inc
|
163.61 | 11.68B | 4.10B | 429.89M | 691.59M | 5.9621 |
|
ISRG
Intuitive Surgical Inc
|
438.10 | 155.76B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
147.63 | 40.30B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
67.78 | 33.13B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
MDLN
Medline Inc
|
37.01 | 31.37B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
RMD
Resmed Inc
|
208.05 | 30.31B | 5.54B | 1.52B | 1.74B | 10.37 |
Align Technology Inc Stock (ALGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-26 | Initiated | Citigroup | Buy |
| Mar-17-26 | Upgrade | Barclays | Equal Weight → Overweight |
| Feb-09-26 | Upgrade | HSBC Securities | Hold → Buy |
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Oct-10-25 | Downgrade | Jefferies | Buy → Hold |
| Jul-31-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-25-25 | Downgrade | HSBC Securities | Buy → Hold |
| Feb-14-25 | Initiated | Wells Fargo | Overweight |
| Jan-06-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-04-24 | Initiated | Mizuho | Outperform |
| Oct-10-24 | Initiated | Needham | Hold |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-11-23 | Downgrade | Goldman | Neutral → Sell |
| Oct-27-23 | Downgrade | UBS | Buy → Neutral |
| Feb-02-23 | Upgrade | Goldman | Sell → Neutral |
| Jul-28-22 | Downgrade | Goldman | Buy → Sell |
| Jan-31-22 | Initiated | Morgan Stanley | Overweight |
| Jan-31-22 | Upgrade | UBS | Neutral → Buy |
| Oct-01-21 | Resumed | Credit Suisse | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-09-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Jul-08-21 | Initiated | Exane BNP Paribas | Outperform |
| Apr-22-21 | Upgrade | Berenberg | Hold → Buy |
| Jan-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-29-20 | Downgrade | Berenberg | Buy → Hold |
| Jul-20-20 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-09-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-24-19 | Reiterated | BofA/Merrill | Neutral |
| Oct-07-19 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-25-19 | Downgrade | Evercore ISI | Outperform → In-line |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Feb-14-19 | Downgrade | UBS | Buy → Neutral |
| Jan-17-19 | Initiated | UBS | Buy |
| Nov-20-18 | Reiterated | Credit Suisse | Outperform |
| Jul-26-18 | Reiterated | Stifel | Buy |
| Jul-13-18 | Reiterated | Stifel | Buy |
| Jun-25-18 | Resumed | BofA/Merrill | Buy |
| May-22-18 | Reiterated | Stifel | Buy |
| May-17-18 | Initiated | Evercore ISI | Outperform |
| Apr-26-18 | Reiterated | Stifel | Buy |
| Apr-20-18 | Initiated | Berenberg | Buy |
| Apr-19-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-08-18 | Initiated | Barclays | Overweight |
View All
Align Technology Inc Stock (ALGN) Latest News
Align Technology to open manufacturing facility in India - Investing.com UK
Align Technology (ALGN) director’s RSUs vest and new 1,836-unit grant - Stock Titan
ALIGN TECHNOLOGY (ALGN) director receives new RSU grant and shares from vesting - Stock Titan
Director Andrea Saia gains stock and RSUs at Align Technology (NASDAQ: ALGN) - Stock Titan
Align Technology (ALGN) director reports RSU vesting and new equity grant - Stock Titan
[Form 4] ALIGN TECHNOLOGY INC Insider Trading Activity - Stock Titan
Align Technology (ALGN) director converts RSUs and receives 2,448-unit equity grant - Stock Titan
Align Technology (ALGN) director gets new RSU grant and shares delivered - Stock Titan
Align Technology (ALGN) director gets 1,836 RSUs, 1,745 vest into shares - Stock Titan
Align Technology (ALGN) director gets 1,836 RSUs, 1,745 shares - Stock Titan
Director at Align Technology (ALGN) receives 1,745 shares from RSU vesting - Stock Titan
Align Technology (ALGN) Announces New Manufacturing Facility in India - GuruFocus
Align Technology (ALGN) to Establish New Manufacturing Facility in India - GuruFocus
Align Technology to open manufacturing facility in India By Investing.com - Investing.com South Africa
Align Technology to Open Manufacturing Plant in India - Moomoo
Align Technology Expands Global Operations With Plans for New Multi-Million Dollar Manufacturing Facility in Hyderabad, India - Yahoo Finance
Precision Trading with Align Technology Inc. (ALGN) Risk Zones - Stock Traders Daily
Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Invisalign maker Align Technology to invest Rs 1,800 crore in Hyderabad plant - The Economic Times
Align Technology (ALGN) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
Align Technology Inc. stock (US0162551016): earnings focus as investors eye next Invisalign growth p - AD HOC NEWS
Align Technology Announces ₹1,800-Crore Investment Plan for Telangana. - News on Projects
Align Technology Hosts 400 Doctors at 2026 Invisalign® EMEA Ortho Summit Featuring Digital Orthodontic Solutions Focused on Clinical Indications and Upcoming Align Innovations - 01net
Align Tech Shareholders Reaffirm Board and Governance Structure - The Globe and Mail
Align Technology reports results of annual stockholder meeting - Investing.com India
Align Technology stock (US01741R1023): Annual meeting and earnings date keep focus on Invisalign - AD HOC NEWS
Align Technology to set up Rs 1,800 crore facility in Hyderabad - Telangana Today
Align Technology Announces Upcoming Investor Conferences - Dentistry Today
U.S. medical device maker Align Tech plans ₹1,800 crore plant in Hyderabad - The Hindu
Align Technology to invest ₹1,800 crore in Telangana - BusinessLine
Align Technology (ALGN) Announces Results of 2026 Annual Meeting of Stockholders - GuruFocus
Will Slowing Growth And Margin Pressure From Competition Change Align Technology's (ALGN) Narrative - simplywall.st
Align Technology Hosts 400 Doctors at 2026 Invisalign® EMEA Orth - GuruFocus
Align Technology Inc. stock (US0162551016): earnings momentum meets volatile sentiment - AD HOC NEWS
Align Technology reports results of annual stockholder meeting By Investing.com - Investing.com South Africa
A Look at Align Technology Inc (ALGN) After 5.3% Gain -- GF Value $238.92 vs Price $163.42 - GuruFocus
Why Align Technology Shares Are Sliding Now - TipRanks
Align Technology Inc. stock outperforms competitors on strong trading day - MarketWatch
Shareholders back Align Technology (NASDAQ: ALGN) board, pay and auditor - Stock Titan
Align Technology to Speak at Upcoming Financial Conferences - The Joplin Globe
Reasons to Add Align Technology Stock to Your Portfolio Now - Yahoo Finance
High Cash Flow Stocks with Weak Returns: Illinois Tool Works, Align Technology, GE HealthCareNews and Statistics - IndexBox
Align Technology Inc. stock (US0162551016): clear aligner specialist in focus after recent share pri - AD HOC NEWS
Align Technology Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
We Like Align Technology's (NASDAQ:ALGN) Earnings For More Than Just Statutory Profit - Sahm
Here's Why Align Technology's Latest Report Might Worry You - AOL.com
Align Technology Inc stock (US01741R1023): strong Q1 2026 earnings keep clear aligner growth story i - AD HOC NEWS
Angelalign Technology Inc. (6699.HK) applauds European court rejection of patent infringement claim - MSN
Align Technology Inc. stock (US0162551016): Rising short interest adds a new angle for investors - AD HOC NEWS
Stifel reiterates Buy rating on Align Technology stock at $210 By Investing.com - Investing.com Australia
Setback for Align and Carpmaels & Ransford in orthodontic aligners dispute - JUVE Patent
Align Technology Inc Stock (ALGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Align Technology Inc Stock (ALGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SIEGEL SUSAN E | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
10,723 |
| Saia Andrea Lynn | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
17,318 |
| Poul Mojdeh | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
3,553 |
| Myong Anne | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
9,830 |
| LARKIN C RAYMOND JR | Director |
May 20 '26 |
Option Exercise |
0.00 |
2,326 |
0 |
27,454 |
| Dallas Kevin J | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
16,168 |
| LACOB JOSEPH | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
135,916 |
| Conroy Kevin T | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
3,553 |
| MORROW GEORGE J | Director |
May 20 '26 |
Option Exercise |
0.00 |
1,745 |
0 |
5,036 |
| Morici John | EVP, CHIEF FINANCIAL OFFICER |
Feb 20 '26 |
Option Exercise |
0.00 |
7,848 |
0 |
16,085 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):